Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127268371 | 12726837 | 1 | I | 20160906 | 20160908 | 20160908 | EXP | FR-009507513-1609FRA002757 | MERCK | 0.00 | F | Y | 0.00000 | 20160908 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127268371 | 12726837 | 1 | PS | EMEND | APREPITANT | 1 | Oral | UNK | Y | 21549 | CAPSULE | ||||||||
| 127268371 | 12726837 | 2 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 6 G SINGLE DOSE | Y | 0 | 6 | G | SOLUTION FOR INJECTION/INFUSION | 1X | |||||
| 127268371 | 12726837 | 3 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 600 MG SIGNAL DOSE | Y | 0 | 600 | MG | 1X | ||||||
| 127268371 | 12726837 | 4 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 300 MG SINGLE DOSE | Y | 0 | 300 | MG | SOLUTION FOR INJECTION/INFUSION | 1X | |||||
| 127268371 | 12726837 | 5 | SS | OXYCODONE | OXYCODONE | 1 | Oral | STRENGTH: PROLONGED RELEASED FILM COATED TABLET, 2 DF, QD | Y | 0 | 40 | MG | FILM-COATED TABLET | QD | |||||
| 127268371 | 12726837 | 6 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | TABLET | |||||||||||
| 127268371 | 12726837 | 7 | C | DIAMICRON | GLICLAZIDE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 8 | C | GRANOCYTE | LENOGRASTIM | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 9 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 10 | C | LASILIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 11 | C | LEVEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 12 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 14 | C | OROZAMUDOL | TRAMADOL | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 15 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 16 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 17 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 18 | C | SOTALOL HYDROCHLORIDE. | SOTALOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 19 | C | TARDYFERON | FERROUS SULFATE | 1 | 0 | ||||||||||||
| 127268371 | 12726837 | 20 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127268371 | 12726837 | 1 | Prophylaxis of nausea and vomiting |
| 127268371 | 12726837 | 2 | B-cell lymphoma stage IV |
| 127268371 | 12726837 | 3 | B-cell lymphoma stage IV |
| 127268371 | 12726837 | 4 | B-cell lymphoma stage IV |
| 127268371 | 12726837 | 5 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127268371 | 12726837 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127268371 | 12726837 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127268371 | 12726837 | 1 | 20160719 | 20160721 | 0 | |
| 127268371 | 12726837 | 2 | 20160721 | 20160721 | 0 | |
| 127268371 | 12726837 | 3 | 20160719 | 20160719 | 0 | |
| 127268371 | 12726837 | 4 | 20160720 | 20160720 | 0 | |
| 127268371 | 12726837 | 5 | 20160721 | 20160722 | 0 |